» Articles » PMID: 33881905

Predictors of Unplanned Hospitalizations Among Older Adults Receiving Cancer Chemotherapy

Abstract

Purpose: Hospitalizations during cancer treatment are costly, can impair quality of life, and negatively affect therapy completion. Our objective was to identify risk factors for unplanned hospitalization among older adults receiving chemotherapy.

Methods: This is a secondary analysis of a multisite cohort study (N = 750) of patients ≥ 65 years of age evaluated with a geriatric assessment (GA) to predict chemotherapy toxicity. The primary outcome of this analysis was unplanned hospitalizations during treatment; the secondary outcome was length of stay (LOS) of the first hospitalization. Independent variables included pretreatment GA measures, laboratory values, cancer type and stage, and treatment intensity characteristics. We used logistic regression to estimate the odds of hospitalization and generalized linear models for LOS in multivariable analyses.

Results: The sample median age was 72 years (range, 65-94 years); 59% had stage IV disease. At least one unplanned hospitalization occurred in 193 patients (25.7%) during receipt of chemotherapy. In multivariable analyses controlling for cancer type, the following baseline characteristics were significantly associated with increased odds of hospitalization: needing help bathing or dressing (odds ratio [OR], 1.8; 95% CI, 1.0 to 3.1), polypharmacy (≥ 5 meds) (OR, 1.6; 95% CI, 1.1 to 2.4), more comorbid conditions (OR, 1.1; 95% CI, 1.0 to 1.3), availability of someone to take them to the doctor (OR, 2.0; 95% CI, 1.0 to 4.1), CrCl < 60 mL/min (OR, 1.7; 95% CI, 1.1 to 2.4), and albumin < 3.5 g/dL (OR, 1.8; 95% CI, 1.2 to 2.8). In multivariable analyses, older age, self-reported presence of liver or kidney disease, living alone and depressive symptoms were associated with longer LOS.

Conclusion: Readily available GA variables and laboratory data, but not age, were associated with unplanned hospitalizations among older adults receiving chemotherapy. If validated, these data can inform prediction models and the design of interventions to decrease unplanned hospitalizations.

Citing Articles

Effect of polypharmacy and potentially inappropriate medications on physical functional decline among older adults with advanced cancer receiving systemic treatment.

Mohamed M, Juba K, Awad H, Flannery M, Culakova E, Wells M Support Care Cancer. 2024; 32(10):674.

PMID: 39294452 DOI: 10.1007/s00520-024-08877-6.


Geriatric Assessment-driven INterventions among Hospitalized older adults with cancer (GAIN-HOSP), a prospective pilot study.

Cabrera Chien L, Sun C, Kim H, Uranga C, Soto-Perez-de-Celis E, Burhenn P J Geriatr Oncol. 2024; 16(1):102063.

PMID: 39271412 PMC: 11824465. DOI: 10.1016/j.jgo.2024.102063.


Associations Between Rehabilitation Utilization and Out-of-Pocket Costs Among Older Adults With Breast Cancer in the United States.

Brick R, Williams C, Deng L, Mollica M, Stout N, Gorzelitz J Arch Phys Med Rehabil. 2024; 105(12):2301-2308.

PMID: 39173732 PMC: 11620952. DOI: 10.1016/j.apmr.2024.08.002.


The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment-driven intervention study.

Jayani R, Hamparsumian A, Sun C, Li D, Cabrera Chien L, Moreno J Cancer. 2024; 130(22):3894-3901.

PMID: 39097801 PMC: 11511632. DOI: 10.1002/cncr.35482.


Addressing Disability in Cancer Survivors.

Brick R, Tonorezos E J Clin Oncol. 2024; 42(19):2239-2241.

PMID: 38723210 PMC: 11382097. DOI: 10.1200/JCO.24.00479.


References
1.
Reed M, Patrick C, Quevillon T, Walde N, Voutsadakis I . Prediction of hospital admissions and grade 3-4 toxicities in cancer patients 70 years old and older receiving chemotherapy. Eur J Cancer Care (Engl). 2019; 28(6):e13144. DOI: 10.1111/ecc.13144. View

2.
Williams G, Dunham L, Chang Y, Deal A, Pergolotti M, Lund J . Geriatric Assessment Predicts Hospitalization Frequency and Long-Term Care Use in Older Adult Cancer Survivors. J Oncol Pract. 2019; 15(5):e399-e409. PMC: 7846045. DOI: 10.1200/JOP.18.00368. View

3.
Jolly T, Deal A, Nyrop K, Williams G, Pergolotti M, Wood W . Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist. 2015; 20(4):379-85. PMC: 4391761. DOI: 10.1634/theoncologist.2014-0247. View

4.
Bush T, Miller S, GOLDEN A, Hale W . Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 1989; 79(11):1554-6. PMC: 1349815. DOI: 10.2105/ajph.79.11.1554. View

5.
Liu M, DuMontier C, Murillo A, Hshieh T, Bean J, Soiffer R . Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies. Blood. 2019; 134(4):374-382. PMC: 6659254. DOI: 10.1182/blood.2019000758. View